본문 바로가기

Hizikia Fusiformis Hexane Extract Decreases Angiogenesis in Vitro and in Vivo

문서 유형
연구출판물 · 학술지 논문
등재
KCI
저널 순위
KCI Q4
저널
생명과학회지33(9) · pp.703 · 2023
피인용
KCI 1
ISSN
1225-9918

저자

  1. 제갈명은제1저자부산대학교 한국나노바이오테크놀러지센터
  2. 한유선부산대학교 한국나노바이오테크놀러지센터
  3. 박시영가천대학교 암·당뇨연구원
  4. 이지혁국립호남권생물자원관
  5. 이의연부산대학교 분자생물학과
  6. 김영진교신저자부산대학교

초록

Angiogenesis, the formation of blood vessels from pre-existing vessels, is a multistep process regulated by modulators of angiogenesis. It is essential for various physiological processes, such as embryonic development, chronic inflammation, and wound repair. Dysregulation of angiogenesis causes many diseases, such as cancer, autoimmune diseases, rheumatoid arthritis, cardiovascular disease, and delayed wound healing. However, the number of effective anti-angiogenic drugs is limited. Recent research has focused on identifying potential drug candidates from natural sources. For example, marine natural products have been shown to have anti-cancer, anti-oxidant, anti-inflammatory, antiviral, and wound- healing effects. Thus, this study aimed to describe the angiogenesis inhibitory effect of Hizikia fusiforms (brown algae) extract. The hexane extract of H. fusiformis has shown inhibitory effects on in vitro angiogenesis assays, such as cell migration, invasion, and tube formation in human umbilical vein endothelial cells (HUVECs). The hexane extract of H. fusiformis (HFH) inhibited in vivo angiogenesis in a mouse Matrigel gel plug assay. In addition, the protein expression of vascular endothelial growth factor (VEGF), mitogen-activated protein kinase (MAPK)/extracellular signal kinase, and AKT serine/threonine kinase 1 decreased following treatment with H. fusiformis extracts. Our results demonstrated that the hexane extract of H. fusiformis (HFH) inhibits angiogenesis in vitro and in vivo.

키워드

Anti-angiogenesisbrown algaeHizikia fusiformisnatural extractsvascular endothelial growth factor (VEGF)

식별자

KCI
ART002999039